Djukovic, Ana http://orcid.org/0000-0001-8068-7188
Garzón, María José http://orcid.org/0000-0002-9136-1236
Canlet, Cécile
Cabral, Vitor
Lalaoui, Rym
García-Garcerá, Marc http://orcid.org/0000-0001-6408-7561
Rechenberger, Julia http://orcid.org/0000-0003-4189-3434
Tremblay-Franco, Marie
Peñaranda, Iván
Puchades-Carrasco, Leonor http://orcid.org/0000-0003-0340-7458
Pineda-Lucena, Antonio
González-Barberá, Eva María
Salavert, Miguel
López-Hontangas, José Luis
Sanz, Miguel Á. http://orcid.org/0000-0003-1489-1177
Sanz, Jaime
Kuster, Bernhard http://orcid.org/0000-0002-9094-1677
Rolain, Jean-Marc
Debrauwer, Laurent
Xavier, Karina B. http://orcid.org/0000-0001-5210-1434
Xavier, Joao B. http://orcid.org/0000-0003-3592-1689
Ubeda, Carles http://orcid.org/0000-0003-0560-4658
Article History
Received: 11 August 2021
Accepted: 9 September 2022
First Online: 24 September 2022
Competing interests
: M.S. has participated as a consultant in advisories and scientific meetings organized or sponsored by the companies GSK, Gilead, MSD, Pfizer, and Shionogi in the last two years, having given lectures for some of them. There is no direct overlap between the current study and these consulting duties. C.U. has participated as a consultant of Vedanta Biosciences and The Zambon Group. There is no direct overlap between the current study and these consulting duties. The rest of the authors do not have competing interest.